| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 26 |
| 1 | AZATHIOPRINE | 25 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 24 |
| 3 | TACROLIMUS OINTMENT 0.1% | 24 |
| 4 | PREDNISONE | 23 |
| 5 | PREDNISOLONE | 19 |
| 6 | PREDNISOLONE ORAL | 19 |
| 7 | PREDNISOLONE ORAL SOLUTION | 19 |
| 8 | METHYLPREDNISOLONE | 17 |
| 9 | MYCOPHENOLATE MOFETIL | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOTANE | 5 | 0.0027 |
| 1 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 2 | LEVONORGESTREL/ETHINYL ESTRADIOL | 1 | 0.0009 |
| 3 | NORETHINDRONE | 4 | 0.0007 |
| 4 | DESOGESTREL AND ETHINYL ESTRADIOL | 2 | 0.0006 |
| 5 | FOLLITROPIN ALFA | 1 | 0.0005 |
| 6 | DACTINOMYCIN | 1 | 0.0005 |
| 7 | TRANEXAMIC ACID | 4 | 0.0004 |
| 8 | FLUVOXAMINE MALEATE | 1 | 0.0004 |
| 9 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 55 |
| 1 | Purine Antimetabolite [EPC] | 25 |
| 2 | Alkylating Drug [EPC] | 14 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 4 | Aromatase Inhibitor [EPC] | 8 |
| 5 | Platinum-based Drug [EPC] | 8 |
| 6 | Estrogen [EPC] | 7 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 6 |
| 8 | Progestin [EPC] | 6 |
| 9 | Antifibrinolytic Agent [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 1 | 0.0005 |
| 1 | Antifibrinolytic Agent [EPC] | 4 | 0.0004 |
| 2 | Purine Antimetabolite [EPC] | 25 | 0.0003 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 4 | Androgen [EPC] | 3 | 0.0001 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Antimalarial [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |